Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech).
| Autor: | Batta S; Texas A&M College of Medicine, Temple, Texas., Miller AC; Center for Clinical Studies, Webster, Texas., Adjei S; Center for Clinical Studies, Webster, Texas., Temiz LA; Center for Clinical Studies, Webster, Texas.; Meharry Medical School, Nashville, Tennessee., Tyring SK; Center for Clinical Studies, Webster, Texas.; Department of Dermatology, University of Texas Health Science Center, Houston, Texas. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2022 Jul 15; Vol. 35 (6), pp. 811-812. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022). |
| DOI: | 10.1080/08998280.2022.2097572 |
| Abstrakt: | We present a case of erythema multiforme (EM) associated with a third (booster) dose of COVID-19 vaccination in a patient who had no cutaneous reactions to previous doses. To our knowledge, this is the first documented case of vaccine-associated EM occurring after a third/booster vaccination. Furthermore, our case emphasizes the need to remain vigilant for vaccine-associated EM in any patient recently vaccinated, regardless of whether previous vaccinations were administered without cutaneous reactions. (Copyright © 2022 Baylor University Medical Center.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|